FM

Forth Management

Europe, Stirling, United Kingdom, Stirling

Description

Forth Management

Investor Profile

Forth Management has made 2 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Post Ipo Equity (50%)
  • Series D (50%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Mhealth
  • Pharmaceutical
  • Software
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Forth Management frequently co-invest with?

Shanda Group
North America, California, United States, Menlo Park
Co-Investments: 2
SoftBank Vision Fund
Europe, England, United Kingdom, London
Co-Investments: 2
5AM Ventures
North America, California, United States, Menlo Park
Co-Investments: 2
Pilot House Ventures
North America, Massachusetts, United States, Boston
Co-Investments: 2
Temasek Holdings
Asia, Central Region, Singapore, Singapore
Co-Investments: 2
QUAD Investment Management
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 2
Sarissa Capital Management
North America, Connecticut, United States, Greenwich
Co-Investments: 2
Jazz Venture Partners
North America, California, United States, San Francisco
Co-Investments: 2
Arboretum Ventures
North America, Michigan, United States, Ann Arbor
Co-Investments: 2
BW
North America, California, United States, Mill Valley
Co-Investments: 1

What are some of recent deals done by Forth Management?

Pear Therapeutics

Boston, Massachusetts, United States

Pear Therapeutics is a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals.

BiotechnologymHealthPharmaceuticalSoftwareTherapeutics
Post Ipo EquityDec 6, 2021
Amount Raised: $125,000,000
Pear Therapeutics

Boston, Massachusetts, United States

Pear Therapeutics is a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals.

BiotechnologymHealthPharmaceuticalSoftwareTherapeutics
Series DDec 8, 2020
Amount Raised: $80,000,000